News Quantified

ENTA – enanta pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Enanta Pharmaceuticals (NASDAQ:ENTA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.

Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook [Yahoo! Finance]

Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook

Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]

Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

1.5%

BEAT

14.1%

BEAT

14.1%

BEAT

14.1%

BEAT

JPMorgan Chase & Co.

Form 4 ENANTA PHARMACEUTICALS For: Dec 05 Filed by: Capps Kathleen S.

Form 4 ENANTA PHARMACEUTICALS For: Dec 05 Filed by: Trout Harry R. III

Form 4 ENANTA PHARMACEUTICALS For: Dec 05 Filed by: Rottinghaus Scott T.

Form 4 ENANTA PHARMACEUTICALS For: Dec 05 Filed by: Luu Brendan

Form 4 ENANTA PHARMACEUTICALS For: Dec 05 Filed by: Kieffer Tara Lynn

Top News Gainers

3/17 Baird likes Enanta's potential in COVID-19, upgrades to Outperform [Seeking Alpha] 11.2%

3/13 Enanta Pharmaceuticals Announces Efforts to Discover a Treatment for the Novel Coronavirus Disease COVID-19 9.2%

2/28 Form 4 ENANTA PHARMACEUTICALS For: Feb 26 Filed by: Russell Lesley 4.1%

5/7 Q2/2019 3/31/2019 EPS 0.200 ZacksConsensus -0.090 ActVsEst 0.290 - Beat 3.8%

2/18 Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Luly Jay R. 3.4%

2/3 Enanta Pharmaceuticals Inc (NASDAQ: ENTA) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 3.3%

8/12 Enanta Pharmaceuticals Inc (NASDAQ: ENTA) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 3.3%

11/22 Enanta Pharmaceuticals Inc (NASDAQ: ENTA) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 3.2%

9/10 New Data from Enanta’s Phase 2a Human Challenge Study of EDP-938 for RSV to be Presented at IDWeek™ 2019 3.2%

6/26 Enanta And AbbVie On EDP-305: Assessing Any Future Collaboration In Liver Diseases [Seeking Alpha] 3.1%

Top News Decliners

3/14 Enanta Pharmaceuticals Inc (NASDAQ: ENTA) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -24.0%

6/14 REFILE-Enanta's lung infection therapy succeeds in mid-stage trial [Reuters] -15.3%

9/25 Enanta Announces Positive Results of ARGON-1 Study of its lead FXR Agonist, EDP-305, for the Treatment of NASH -15.1%

4/30 Enanta Pharmaceuticals Inc (NASDAQ: ENTA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -5.8%

3/26 Enanta Provides Update on Clinical Development Activities During COVID-19 Pandemic -5.4%

2/10 Form 10-Q ENANTA PHARMACEUTICALS For: Dec 31 -5.2%

11/21 Q4/2019 9/30/2019 EPS 0.440 ZacksConsensus 0.560 ActVsEst (0.120) - Miss -4.4%

5/10 Form 10-Q ENANTA PHARMACEUTICALS For: Mar 31 -4.3%

6/22 Enanta Pharmaceuticals Inc (NASDAQ: ENTA) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -4.2%

1/24 Enanta Pharmaceuticals Inc (NASDAQ: ENTA) was downgraded by analysts at ValuEngine from a "strong-buy" rating to a "buy" rating. -3.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day